Appointment

Suspendisse interdum consectetur libero id. Fermentum leo vel orci porta non. Euismod viverra nibh cras pulvinar suspen.

Dr. Nikhil Himthani

Home / Doctor / Dr. Nikhil Himthani

Dr. Nikhil Himthani is a medical oncologist with 10 years of experience in the field of oncology. Graduated from GMC Haldwani, MD from IGMC Shimla, and DM in Medical Oncology and Hemato-Oncology from the renowned GCRI. He is well trained and experienced in the treatment of all solid and hematologic malignancies in adult and pediatric patients with a strong interest in immunotherapy and breast cancer.

  • Designation: Consultant
  • Department : Medical Oncology and Hemato-Oncology

Area of Interest 

  • Breast cancer
  • Head and neck cancer
  • Lung cancer
  • Multiple myeloma
  • Lymphoma
  • Acute and chronic leukemia
  • Prostate cancer
  • Sarcomas
  • Brain tumor
  • Bone tumors
  • Gastrointestinal cancer
  • Gynecological cancer
  • Genitourinary cancers

Education & Training 

  • Doctorate of Medicine, (DM)-Medical Oncology 2nd Rank Gujarat Cancer Research Institute Ahmedabad, India (August 2018-August 2021)
  • Doctor of Medicine (MD)-GOLD MEDALIST Indira Gandhi Medical College Shimla. (2013-2016)
  • Bachelor of Medicine and Bachelor of Surgery (MBBS) Government Medical College, Haldwani, Uttarakhand, India. (2007-2012)
  • Co-investigator in Clinical trial during DM residency. (ORION STUDY)
  • AROICON 2015, Delhi- First prize in paper presentation
  • AROICON 2015, Delhi-Second Prize in Quiz

 

Awards, Honours, & Memberships 

  • Extensive Use of Systemic Chemotherapy for Solid and Hematological Malignancies.
  • Extensive Use of Targeted Therapies Available in India.
  • Several immuno-oncology drugs are available in India.
  • Pain Management and Palliative support including end-of-life care.
  • Management of Oncological Emergencies and ICU care.
  • Oncological Procedures-Central Venous device (PORT/PICC/Central lines) handling, Lumbar Puncture, and Bone Marrow Biopsy.
  • Management of Chemotherapy toxicities, Monoclonal Antibodies, and Immunologic ADRs.
  • ISMPO ASCO ESMO.
  • Tocilizumab treatment and outcomes in severe COVID-19 patients: Retrospective Study from a tertiary care institute in western India. They were published in JMSR in December 2020.
  • Acute Leukemia in Pregnancy: Case series from a Tertiary Care Institute. Published in JMSR in April 2021.

Experience

  • Consultant-Medical Oncology, IOCI, ICI Hospital Greater Kailash Delhi 2024.
  • Consultant Medical Oncologist at Batra Hospital Delhi 2023.
  • Associate Consultant Medical Oncology at Action Cancer Hospital 2021-2023.
  • Senior Resident Max Hospital Saket 2016-2018.
Hi, I am online to help you!